Kahsiang personal page - To The Moon

Kahsiang

Kahsiang

Profile：Learn nothing be free

7Follow

1Followers

0Topic

0Badge

2021-06-22

Fake

Sorry, the original content has been removed

2021-06-22

Lklpx

These 3 Dow Stocks Are Set to Soar in 2021's Second Half

2022-01-27

I love this game

@TigerEvents:Join Tiger Ski Championship, Win a Bonus of Up to USD 2022

2021-06-22

Xrp i think will moon

Sorry, the original content has been removed

2021-06-22

I thikk no leh

Sorry, the original content has been removed

2022-01-27

Pltr will moon soon ipo price rn

2021-12-27

I think xrp will moon

2021-06-22

Daftpunk better

Sorry, the original content has been removed

2021-06-22

Nice

Sorry, the original content has been removed

2021-06-22

Xrp to the moon

Sorry, the original content has been removed

2021-06-22

Hi! I truly xrp to the moon and i am allIn what about you?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3586344416928957,"uuid":"3586344416928957","gmtCreate":1623250965476,"gmtModify":1624360683199,"name":"Kahsiang","pinyin":"kahsiang","introduction":"","introductionEn":"","signature":"Learn nothing be free","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":7,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.87%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9099041601,"gmtCreate":1643283522511,"gmtModify":1676533795948,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I love this game","listText":"I love this game","text":"I love this game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099041601","repostId":"9004448317","repostType":1,"repost":{"id":9004448317,"gmtCreate":1642676525258,"gmtModify":1676533734534,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Join Tiger Ski Championship, Win a Bonus of Up to USD 2022","htmlText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","listText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","text":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: Click to Join the Game","images":[{"img":"https://static.tigerbbs.com/a7b44fa056439fb4010fa55e163d27c3","width":"750","height":"1726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004448317","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9099043316,"gmtCreate":1643283386202,"gmtModify":1676533795923,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Pltr will moon soon ipo price rn","listText":"Pltr will moon soon ipo price rn","text":"Pltr will moon soon ipo price rn","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099043316","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009883991,"gmtCreate":1640610145877,"gmtModify":1676533528807,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I think xrp will moon","listText":"I think xrp will moon","text":"I think xrp will moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009883991","isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129389626,"gmtCreate":1624359293065,"gmtModify":1703834302168,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Xrp i think will moon","listText":"Xrp i think will moon","text":"Xrp i think will moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129389626","repostId":"2145803031","repostType":4,"repost":{"id":"2145803031","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1624344420,"share":"https://www.laohu8.com/m/news/2145803031?lang=&edition=full","pubTime":"2021-06-22 14:47","market":"us","language":"en","title":"10, 30-year Treasury yields recover overnight dip to stage solid post-Fed climb Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2145803031","media":"Dow Jones","summary":"Yields for benchmark bonds on Monday climb higher on the long-end for the curve, with the long bond ","content":"<p>Yields for benchmark bonds on Monday climb higher on the long-end for the curve, with the long bond notching its sharpest yield climb since March. The moves come as investors continue to position following a Federal Reserve update last week that was interpreted as more inclined to end pandemic-era accommodations sooner than later, even as the central bank views surging pricing pressures as likely to be short-lived.</p>\n<p><b>How Treasurys performed</b></p>\n<p>Fixed-income drivers</p>\n<p>Strategists didn't offer an clear reason why yields turned lower and then popped up, but some attribute it to bearish positioning, with investors forced to unwind bets that prices would head lower, pushing yields higher.</p>\n<p>Read:Markets are sending 'peculiar' signals as Fed changes tune--here's what they mean</p>\n<p>In theory, the Fed's stance that post-COVID inflation pressures should be short-lived and the expectation that the Fed could begin raising rates as early as late 2022 or early 2023, should be nudging yields higher.</p>\n<p>But bond yields, which move opposite to prices, have been reluctant to hold higher for an extended period in benchmark 30-year and 10-year Treasurys, which are used to price everything from mortgages to corporate bonds.</p>\n<p>On Monday, both St. Louis Fed President James Bullard and Dallas Fed President Rob Kaplan said they expect the pace of inflation next year to remain above the central bank's target.</p>\n<p>Last Friday, Bullard, in interview with CNBC, suggested that he would be inclined to see the Fed lift interest rates by late 2022 and said that Fed Chairman Jerome Powell has effectively opened the door to tapering the central bank's monthly purchases of $120 billion in Treasurys and mortgage-backed securities.</p>\n<p>The market will hear from Powell again on Tuesday when he testifies before the House select subcommittee on the impact of the coronavirus on the economy.</p>\n<p><b>What strategists said</b></p>\n<p>Inflation-themed \"trades such as a bear-steepening of the curve and a weaker dollar depend on the Fed remaining dovish, with the implication that a hawkish Fed would move markets in reverse,\" wrote Alex Pelle and Steven Ricchiuto, U.S. economists at Mizuho, in an afternoon note.</p>\n<p>\"Our view is that Powell remains solidly on the dovish end of the FOMC, but he is a Chair trying to manage an increasingly factious committee as incoming inflation data surprises to the upside.\"</p>\n<p>Still, the trajectory of monetary, including any pullback, will hinge on the labor market recovery, the team wrote, adding that with the \"realistic unemployment rate closer to 7.9%,\" realizing the \"gargantuan task\" of a 4.5% unemployment rate by year-end would be difficult and \"require job growth averaging around 900K job additions per month for the next 6 months.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10, 30-year Treasury yields recover overnight dip to stage solid post-Fed climb Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10, 30-year Treasury yields recover overnight dip to stage solid post-Fed climb Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-22 14:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Yields for benchmark bonds on Monday climb higher on the long-end for the curve, with the long bond notching its sharpest yield climb since March. The moves come as investors continue to position following a Federal Reserve update last week that was interpreted as more inclined to end pandemic-era accommodations sooner than later, even as the central bank views surging pricing pressures as likely to be short-lived.</p>\n<p><b>How Treasurys performed</b></p>\n<p>Fixed-income drivers</p>\n<p>Strategists didn't offer an clear reason why yields turned lower and then popped up, but some attribute it to bearish positioning, with investors forced to unwind bets that prices would head lower, pushing yields higher.</p>\n<p>Read:Markets are sending 'peculiar' signals as Fed changes tune--here's what they mean</p>\n<p>In theory, the Fed's stance that post-COVID inflation pressures should be short-lived and the expectation that the Fed could begin raising rates as early as late 2022 or early 2023, should be nudging yields higher.</p>\n<p>But bond yields, which move opposite to prices, have been reluctant to hold higher for an extended period in benchmark 30-year and 10-year Treasurys, which are used to price everything from mortgages to corporate bonds.</p>\n<p>On Monday, both St. Louis Fed President James Bullard and Dallas Fed President Rob Kaplan said they expect the pace of inflation next year to remain above the central bank's target.</p>\n<p>Last Friday, Bullard, in interview with CNBC, suggested that he would be inclined to see the Fed lift interest rates by late 2022 and said that Fed Chairman Jerome Powell has effectively opened the door to tapering the central bank's monthly purchases of $120 billion in Treasurys and mortgage-backed securities.</p>\n<p>The market will hear from Powell again on Tuesday when he testifies before the House select subcommittee on the impact of the coronavirus on the economy.</p>\n<p><b>What strategists said</b></p>\n<p>Inflation-themed \"trades such as a bear-steepening of the curve and a weaker dollar depend on the Fed remaining dovish, with the implication that a hawkish Fed would move markets in reverse,\" wrote Alex Pelle and Steven Ricchiuto, U.S. economists at Mizuho, in an afternoon note.</p>\n<p>\"Our view is that Powell remains solidly on the dovish end of the FOMC, but he is a Chair trying to manage an increasingly factious committee as incoming inflation data surprises to the upside.\"</p>\n<p>Still, the trajectory of monetary, including any pullback, will hinge on the labor market recovery, the team wrote, adding that with the \"realistic unemployment rate closer to 7.9%,\" realizing the \"gargantuan task\" of a 4.5% unemployment rate by year-end would be difficult and \"require job growth averaging around 900K job additions per month for the next 6 months.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145803031","content_text":"Yields for benchmark bonds on Monday climb higher on the long-end for the curve, with the long bond notching its sharpest yield climb since March. The moves come as investors continue to position following a Federal Reserve update last week that was interpreted as more inclined to end pandemic-era accommodations sooner than later, even as the central bank views surging pricing pressures as likely to be short-lived.\nHow Treasurys performed\nFixed-income drivers\nStrategists didn't offer an clear reason why yields turned lower and then popped up, but some attribute it to bearish positioning, with investors forced to unwind bets that prices would head lower, pushing yields higher.\nRead:Markets are sending 'peculiar' signals as Fed changes tune--here's what they mean\nIn theory, the Fed's stance that post-COVID inflation pressures should be short-lived and the expectation that the Fed could begin raising rates as early as late 2022 or early 2023, should be nudging yields higher.\nBut bond yields, which move opposite to prices, have been reluctant to hold higher for an extended period in benchmark 30-year and 10-year Treasurys, which are used to price everything from mortgages to corporate bonds.\nOn Monday, both St. Louis Fed President James Bullard and Dallas Fed President Rob Kaplan said they expect the pace of inflation next year to remain above the central bank's target.\nLast Friday, Bullard, in interview with CNBC, suggested that he would be inclined to see the Fed lift interest rates by late 2022 and said that Fed Chairman Jerome Powell has effectively opened the door to tapering the central bank's monthly purchases of $120 billion in Treasurys and mortgage-backed securities.\nThe market will hear from Powell again on Tuesday when he testifies before the House select subcommittee on the impact of the coronavirus on the economy.\nWhat strategists said\nInflation-themed \"trades such as a bear-steepening of the curve and a weaker dollar depend on the Fed remaining dovish, with the implication that a hawkish Fed would move markets in reverse,\" wrote Alex Pelle and Steven Ricchiuto, U.S. economists at Mizuho, in an afternoon note.\n\"Our view is that Powell remains solidly on the dovish end of the FOMC, but he is a Chair trying to manage an increasingly factious committee as incoming inflation data surprises to the upside.\"\nStill, the trajectory of monetary, including any pullback, will hinge on the labor market recovery, the team wrote, adding that with the \"realistic unemployment rate closer to 7.9%,\" realizing the \"gargantuan task\" of a 4.5% unemployment rate by year-end would be difficult and \"require job growth averaging around 900K job additions per month for the next 6 months.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129389358,"gmtCreate":1624359277674,"gmtModify":1703834301683,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Daftpunk better","listText":"Daftpunk better","text":"Daftpunk better","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129389358","repostId":"1139414035","repostType":4,"repost":{"id":"1139414035","pubTimestamp":1624345572,"share":"https://www.laohu8.com/m/news/1139414035?lang=&edition=full","pubTime":"2021-06-22 15:06","market":"us","language":"en","title":"DraftKings' Stumble Offers An Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1139414035","media":"seekingalpha","summary":"Summary\n\nDraftKings has pulled back after a broader pullback on growth stocks and a short report tar","content":"<p><b>Summary</b></p>\n<ul>\n <li>DraftKings has pulled back after a broader pullback on growth stocks and a short report targeting the betting company.</li>\n <li>However, DraftKings continues to grow at a torrid pace and innovate along the way.</li>\n <li>DraftKings offers a more compelling risk/reward after a 20% drop since my last look at them.</li>\n</ul>\n<p>Fantasy sports and betting platform DraftKings Inc. (DKNG) has steadily slid lower since mid-March. The most recent piece of bad news, a short report, claimed that the company is concealing illegal activities. Shares have come down 35% from highs.</p>\n<p>However, at an operational level, DraftKings continues to grow and innovate. The company posted strong Q1 results and is investing heavily to lay the groundwork to be the primary player in sports betting, an industry that is continuing to blossom. While DraftKings continues to carry some risks that investors should be aware of, the pullback has offered a more compelling risk/reward entry for investors.</p>\n<p><b>DraftKings Continues To Grow &amp; Innovate</b></p>\n<p>DraftKings reported its Q1 earnings for 2021 in May, and results showed a glimpse into the company's continued upward trajectory. The business is growing at a rapid rate and continues to innovate.</p>\n<p>For the quarter, DraftKings reported revenues of $312 million, year over year growth of 175% on a Pro-forma basis. This growth was driven in part by new state launches in Michigan and Virginia. The betting and iGaming landscape is still developing, so new state launches will continue to play an important role in growth for the foreseeable future.</p>\n<p>Additionally, DraftKings is innovating to drive engagement (and thus revenue growth) on the platform. It recently launched \"Spanish 21\", a variant game of Blackjack, and it is currently unique among iGaming operators to DraftKings.</p>\n<p><img src=\"https://static.tigerbbs.com/38bef09e9a4a3b68cab2d9bc336ac15b\" tg-width=\"640\" tg-height=\"192\"></p>\n<p>Source: DraftKings Inc.</p>\n<p>The more impactful innovation that DraftKings is working on is the features that it is adding to turn DraftKings into a one-stop-shop platform for a gaming experience. There are two great examples of this in the works. DraftKings is collaborating with SLING TV to launch sports betting information channels. This ties real-time sports updates into betting odds, producing a more engaging experience for customers.</p>\n<p><img src=\"https://static.tigerbbs.com/ca4d93bb27aaf7fd36bdfc6e3734a43a\" tg-width=\"640\" tg-height=\"199\"></p>\n<p>Source: DraftKings Inc.</p>\n<p>DraftKings is also launching social media features on its platform that will allow customers to interact with each other by friending, commenting, and sharing bets with others.</p>\n<p><img src=\"https://static.tigerbbs.com/5a5c6faace4c411e5a7e2976c2ae702f\" tg-width=\"640\" tg-height=\"384\"></p>\n<p>Source: DraftKings Inc.</p>\n<p>This is a great opportunity for DraftKings, as there are high-profile gamblers on traditional social media platforms already that prove this concept out. I wouldn't be surprised to see DraftKings spending to bring high-profile bettors onto DraftKings' platform as an effort to attract followers that can \"play along\" with these betting celebrities.</p>\n<p><b>About The Short Report</b></p>\n<p>Shares of DraftKings took a recent tumble when a short report emerged, accusing the company of concealing illegal activity from the public.</p>\n<p><i>Investors should consider every bear case, soyou can find it herefor those interested in checking it out.</i></p>\n<p>The report is based on a lot of insinuation (typical of short reports), so I won't go into a ton of detail here. The basic point of the report is that a segment of DraftKings known as SBTech before the SPAC merger is involved in black market dealings, and it's being hidden from regulators and investors.</p>\n<p>I didn't find enough credible evidence of this upon reading the report, and I like to think that all of the partnerships that DraftKings has amassed are a sign of things being done properly. Nonetheless, investors can read and decide for themselves.</p>\n<p><b>The Risk That Investors Should Keep Eyes On</b></p>\n<p>If there is a legitimate reason for caution on DraftKings, I believe it to be the company's rapid cash-burning that continues to take place.</p>\n<p><i>I wrote about it in my previous article on DraftKings,which can be found here.</i></p>\n<p>DraftKings aggressively spends on sales and marketing to grow revenue, as we can see that this expense category alone almost eclipses revenues despite the company's top-line growth.</p>\n<p><img src=\"https://static.tigerbbs.com/f23d5da6dc7f5d0125f90532f866e141\" tg-width=\"640\" tg-height=\"390\"></p>\n<p>Source: YCharts</p>\n<p>As I detailed in my previous article, DraftKings is spending to grab market share in an emerging industry. Don't forget that a lot of this spending will also aggressively market in newly launched states. Eventual profitability is important over the long term, but part of this process is for DraftKings to acquire the scale needed to maximize the unit economics of the business.</p>\n<p>There are signs that DraftKings has had success thus far. In Q1, the company's ARPU (average revenue per user) was $61, a notable increase over the $41 it generated a year ago.</p>\n<p>This is something that investors will need to continue monitoring. What will be key is the eventual plateau of marketing spend as the platform grows large enough to draw users in more organically.</p>\n<p><b>A More Compelling Entry Point</b></p>\n<p>Shares of DraftKings have cooled slightly over the past several months, now sitting about 35% below highs at $48 per share.</p>\n<p><img src=\"https://static.tigerbbs.com/947874e9faff15a78a04538a5298d35b\" tg-width=\"640\" tg-height=\"384\"></p>\n<p>Source: YCharts</p>\n<p>Based on analyst estimates, DraftKings is currently trading at an EV/sales of 15X on a forward basis. With analysts projecting strong growth over the coming years (90% in 2021 and high 30s after that), DraftKings offers an attractive entry point that will see multiples aggressively compress over the short-medium time frames as growth continues.</p>\n<p><b>Wrapping Up</b></p>\n<p>DraftKings is growing \"at all costs,\" so there is risk involved in the near term. However, the recent pullback gives investors a margin of safety because strong revenue growth will quickly compress valuations from here. The company's revenues are poised to continue expanding rapidly as the iGaming and sports betting markets come into their own. Eventually, profitability will become a more critical aspect of the business, but that time isn't now.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DraftKings' Stumble Offers An Opportunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDraftKings' Stumble Offers An Opportunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 15:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435911-draftkings-stumble-offers-an-opportunity><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nDraftKings has pulled back after a broader pullback on growth stocks and a short report targeting the betting company.\nHowever, DraftKings continues to grow at a torrid pace and innovate ...</p>\n\n<a href=\"https://seekingalpha.com/article/4435911-draftkings-stumble-offers-an-opportunity\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DKNG":"DraftKings Inc."},"source_url":"https://seekingalpha.com/article/4435911-draftkings-stumble-offers-an-opportunity","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1139414035","content_text":"Summary\n\nDraftKings has pulled back after a broader pullback on growth stocks and a short report targeting the betting company.\nHowever, DraftKings continues to grow at a torrid pace and innovate along the way.\nDraftKings offers a more compelling risk/reward after a 20% drop since my last look at them.\n\nFantasy sports and betting platform DraftKings Inc. (DKNG) has steadily slid lower since mid-March. The most recent piece of bad news, a short report, claimed that the company is concealing illegal activities. Shares have come down 35% from highs.\nHowever, at an operational level, DraftKings continues to grow and innovate. The company posted strong Q1 results and is investing heavily to lay the groundwork to be the primary player in sports betting, an industry that is continuing to blossom. While DraftKings continues to carry some risks that investors should be aware of, the pullback has offered a more compelling risk/reward entry for investors.\nDraftKings Continues To Grow & Innovate\nDraftKings reported its Q1 earnings for 2021 in May, and results showed a glimpse into the company's continued upward trajectory. The business is growing at a rapid rate and continues to innovate.\nFor the quarter, DraftKings reported revenues of $312 million, year over year growth of 175% on a Pro-forma basis. This growth was driven in part by new state launches in Michigan and Virginia. The betting and iGaming landscape is still developing, so new state launches will continue to play an important role in growth for the foreseeable future.\nAdditionally, DraftKings is innovating to drive engagement (and thus revenue growth) on the platform. It recently launched \"Spanish 21\", a variant game of Blackjack, and it is currently unique among iGaming operators to DraftKings.\n\nSource: DraftKings Inc.\nThe more impactful innovation that DraftKings is working on is the features that it is adding to turn DraftKings into a one-stop-shop platform for a gaming experience. There are two great examples of this in the works. DraftKings is collaborating with SLING TV to launch sports betting information channels. This ties real-time sports updates into betting odds, producing a more engaging experience for customers.\n\nSource: DraftKings Inc.\nDraftKings is also launching social media features on its platform that will allow customers to interact with each other by friending, commenting, and sharing bets with others.\n\nSource: DraftKings Inc.\nThis is a great opportunity for DraftKings, as there are high-profile gamblers on traditional social media platforms already that prove this concept out. I wouldn't be surprised to see DraftKings spending to bring high-profile bettors onto DraftKings' platform as an effort to attract followers that can \"play along\" with these betting celebrities.\nAbout The Short Report\nShares of DraftKings took a recent tumble when a short report emerged, accusing the company of concealing illegal activity from the public.\nInvestors should consider every bear case, soyou can find it herefor those interested in checking it out.\nThe report is based on a lot of insinuation (typical of short reports), so I won't go into a ton of detail here. The basic point of the report is that a segment of DraftKings known as SBTech before the SPAC merger is involved in black market dealings, and it's being hidden from regulators and investors.\nI didn't find enough credible evidence of this upon reading the report, and I like to think that all of the partnerships that DraftKings has amassed are a sign of things being done properly. Nonetheless, investors can read and decide for themselves.\nThe Risk That Investors Should Keep Eyes On\nIf there is a legitimate reason for caution on DraftKings, I believe it to be the company's rapid cash-burning that continues to take place.\nI wrote about it in my previous article on DraftKings,which can be found here.\nDraftKings aggressively spends on sales and marketing to grow revenue, as we can see that this expense category alone almost eclipses revenues despite the company's top-line growth.\n\nSource: YCharts\nAs I detailed in my previous article, DraftKings is spending to grab market share in an emerging industry. Don't forget that a lot of this spending will also aggressively market in newly launched states. Eventual profitability is important over the long term, but part of this process is for DraftKings to acquire the scale needed to maximize the unit economics of the business.\nThere are signs that DraftKings has had success thus far. In Q1, the company's ARPU (average revenue per user) was $61, a notable increase over the $41 it generated a year ago.\nThis is something that investors will need to continue monitoring. What will be key is the eventual plateau of marketing spend as the platform grows large enough to draw users in more organically.\nA More Compelling Entry Point\nShares of DraftKings have cooled slightly over the past several months, now sitting about 35% below highs at $48 per share.\n\nSource: YCharts\nBased on analyst estimates, DraftKings is currently trading at an EV/sales of 15X on a forward basis. With analysts projecting strong growth over the coming years (90% in 2021 and high 30s after that), DraftKings offers an attractive entry point that will see multiples aggressively compress over the short-medium time frames as growth continues.\nWrapping Up\nDraftKings is growing \"at all costs,\" so there is risk involved in the near term. However, the recent pullback gives investors a margin of safety because strong revenue growth will quickly compress valuations from here. The company's revenues are poised to continue expanding rapidly as the iGaming and sports betting markets come into their own. Eventually, profitability will become a more critical aspect of the business, but that time isn't now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129380233,"gmtCreate":1624359259622,"gmtModify":1703834301199,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Fake","listText":"Fake","text":"Fake","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129380233","repostId":"1177499959","repostType":4,"isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129380832,"gmtCreate":1624359246026,"gmtModify":1703834301037,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129380832","repostId":"1186855284","repostType":4,"repost":{"id":"1186855284","pubTimestamp":1624345153,"share":"https://www.laohu8.com/m/news/1186855284?lang=&edition=full","pubTime":"2021-06-22 14:59","market":"us","language":"en","title":"If You Thought These 2 Big Nasdaq Winners Were Done, Think Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1186855284","media":"Motley Fool","summary":"On a strong day for the Nasdaq, two highfliers stood out.\n\nVolatility has returned to the stock mark","content":"<blockquote>\n On a strong day for the Nasdaq, two highfliers stood out.\n</blockquote>\n<p>Volatility has returned to the stock market, but finally, the<b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC)is starting to make waves once again. The tech-heavy index is making a run toward all-time highs, trading within 1% of its high-water mark on Monday afternoon. As of just before 2 p.m. EDT today,the Nasdaq&nbsp; was higher by three-quarters of a percent.</p>\n<p>It wasn't that long ago that investors figured that stocks of COVID-19 vaccine manufacturers had already seen their best days. Companies like<b>Moderna</b>(NASDAQ:MRNA)and<b>BioNTech</b>(NASDAQ:BNTX)had seen their share prices start to give up ground as many believed that a vaccinated world would eventually cause revenue and profits to dry up for the vaccine makers. Now, though, it's becoming increasingly clear that the two companies could well have a much brighter future than many had thought.</p>\n<p><b>More moves for Moderna and BioNTech</b></p>\n<p>Shares of the vaccine manufacturers were among the leaders on the Nasdaq today. Moderna's gains amounted to more than 5%, while BioNTech boasted gains of 6% or more on the day.</p>\n<p>The general sentiment toward BioNTech and Moderna has been positive because ofjust how effective their vaccines have been. Last month, the U.S. Centers for Disease Control and Prevention released the latest figures on efficacy for the messenger-RNA-based vaccines from the two companies. Data from real-life use showed a reduction in infection risks of 91%. Those who got infected had a 60% lower risk of showing symptoms, and they spent on average six days fewer being sick and two days fewer stuck in bed recovering.</p>\n<p>In addition, the companies have benefited from sustained demand for COVID vaccines from countries around the world. On Monday,BioNTech said that it had received provision approvalof its vaccine from regulators in New Zealand. Over the weekend, the government of the Philippines announced a 40-million-dose agreement with BioNTech and<b>Pfizer</b>(NYSE:PFE)for more vaccine doses as well.</p>\n<p>More broadly, some health officials have started talking about the potential need for vaccine booster shots. It's uncertain at this point whether and how quickly antibody levels from initial vaccinations decline, and so it's entirely possible that even those who've already received vaccinations could need additional doses in the future. From a business standpoint, that would create even further demand for Moderna and BioNTech that could dramatically lengthen the expected flow of revenue stemming from COVID vaccines.</p>\n<p><b>Will existing vaccines be enough?</b></p>\n<p>The biggest threat on the COVID front comes from the potential for the virus to mutate into more-dangerous variants. Already, theDelta varianthas proved to be more easily transmitted among infected patients and with more-severe health impacts. Future variants could prove even more problematic, and there's no guarantee that existing vaccines will provide protection against them all.</p>\n<p>For the most part, both Moderna's and BioNTech's stock prices seem to reflect little expectation of success beyond the current COVID vaccine products. Yet if anything, COVID has proved that the broader-based investing thesis behind mRNA-based treatment development is sound. Both companies have plans for vaccines and other treatments for a wider variety of different medical conditions, and success anywhere on that front could provide the positive surprise investors need to gain confidence in the long-term futures of these stocks.</p>\n<p>If you made the mistake of thinking that COVID vaccine stocks would be done once much of the U.S. population had been vaccinated, you aren't alone. But you might be surprised at how much staying power BioNTech and Moderna could have -- especially if a few things end up working out in their favor.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If You Thought These 2 Big Nasdaq Winners Were Done, Think Again</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf You Thought These 2 Big Nasdaq Winners Were Done, Think Again\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 14:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/21/if-you-thought-big-nasdaq-winners-done-think-again/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On a strong day for the Nasdaq, two highfliers stood out.\n\nVolatility has returned to the stock market, but finally, theNasdaq Composite(NASDAQINDEX:^IXIC)is starting to make waves once again. The ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/21/if-you-thought-big-nasdaq-winners-done-think-again/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","BNTX":"BioNTech SE"},"source_url":"https://www.fool.com/investing/2021/06/21/if-you-thought-big-nasdaq-winners-done-think-again/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186855284","content_text":"On a strong day for the Nasdaq, two highfliers stood out.\n\nVolatility has returned to the stock market, but finally, theNasdaq Composite(NASDAQINDEX:^IXIC)is starting to make waves once again. The tech-heavy index is making a run toward all-time highs, trading within 1% of its high-water mark on Monday afternoon. As of just before 2 p.m. EDT today,the Nasdaq  was higher by three-quarters of a percent.\nIt wasn't that long ago that investors figured that stocks of COVID-19 vaccine manufacturers had already seen their best days. Companies likeModerna(NASDAQ:MRNA)andBioNTech(NASDAQ:BNTX)had seen their share prices start to give up ground as many believed that a vaccinated world would eventually cause revenue and profits to dry up for the vaccine makers. Now, though, it's becoming increasingly clear that the two companies could well have a much brighter future than many had thought.\nMore moves for Moderna and BioNTech\nShares of the vaccine manufacturers were among the leaders on the Nasdaq today. Moderna's gains amounted to more than 5%, while BioNTech boasted gains of 6% or more on the day.\nThe general sentiment toward BioNTech and Moderna has been positive because ofjust how effective their vaccines have been. Last month, the U.S. Centers for Disease Control and Prevention released the latest figures on efficacy for the messenger-RNA-based vaccines from the two companies. Data from real-life use showed a reduction in infection risks of 91%. Those who got infected had a 60% lower risk of showing symptoms, and they spent on average six days fewer being sick and two days fewer stuck in bed recovering.\nIn addition, the companies have benefited from sustained demand for COVID vaccines from countries around the world. On Monday,BioNTech said that it had received provision approvalof its vaccine from regulators in New Zealand. Over the weekend, the government of the Philippines announced a 40-million-dose agreement with BioNTech andPfizer(NYSE:PFE)for more vaccine doses as well.\nMore broadly, some health officials have started talking about the potential need for vaccine booster shots. It's uncertain at this point whether and how quickly antibody levels from initial vaccinations decline, and so it's entirely possible that even those who've already received vaccinations could need additional doses in the future. From a business standpoint, that would create even further demand for Moderna and BioNTech that could dramatically lengthen the expected flow of revenue stemming from COVID vaccines.\nWill existing vaccines be enough?\nThe biggest threat on the COVID front comes from the potential for the virus to mutate into more-dangerous variants. Already, theDelta varianthas proved to be more easily transmitted among infected patients and with more-severe health impacts. Future variants could prove even more problematic, and there's no guarantee that existing vaccines will provide protection against them all.\nFor the most part, both Moderna's and BioNTech's stock prices seem to reflect little expectation of success beyond the current COVID vaccine products. Yet if anything, COVID has proved that the broader-based investing thesis behind mRNA-based treatment development is sound. Both companies have plans for vaccines and other treatments for a wider variety of different medical conditions, and success anywhere on that front could provide the positive surprise investors need to gain confidence in the long-term futures of these stocks.\nIf you made the mistake of thinking that COVID vaccine stocks would be done once much of the U.S. population had been vaccinated, you aren't alone. But you might be surprised at how much staying power BioNTech and Moderna could have -- especially if a few things end up working out in their favor.","news_type":1},"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129316188,"gmtCreate":1624358845344,"gmtModify":1703834293573,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I thikk no leh","listText":"I thikk no leh","text":"I thikk no leh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129316188","repostId":"1124495234","repostType":4,"repost":{"id":"1124495234","pubTimestamp":1624352353,"share":"https://www.laohu8.com/m/news/1124495234?lang=&edition=full","pubTime":"2021-06-22 16:59","market":"us","language":"en","title":"The Fed Has Spoken: Stocks To Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1124495234","media":"seekingalpha","summary":"Summary\n\nThe Fed could begin raising rates sooner than 2023.\nHealthcare and utilities are climbing o","content":"<p><b>Summary</b></p>\n<ul>\n <li>The Fed could begin raising rates sooner than 2023.</li>\n <li>Healthcare and utilities are climbing our sector ranking.</li>\n <li>The top stocks in our universe today.</li>\n</ul>\n<p>As I wrote last week,inflation is here. Earlier this week, the Federal Reserve's Federal Open Market Committee made its most significant hawkish shift yet, accelerating its timeline for hiking the Federal Funds rate to 2023 from 2024 and setting the table to end asset repurchases as soon as this year.</p>\n<p>The Central Bank left little doubt government's one-two monetary and fiscal punch has reinvigorated economic activity. Exiting the meeting, bankers believe gross domestic product, or GDP, willgrow 7%this year, up from its 6.5% forecast in March, resulting in core inflation of 3%, up from its prior outlook for 2.2%.</p>\n<p>Historically, the Federal Reserve has a reputation for under estimating inflationary pressure, forcing it to act more quickly and aggressively than it originally signals. Whether this means the Fed is behind the inflationary curve now is anyone's guess, but if it is, then we may see an even more hawkish tone over the coming year.</p>\n<p>For now, the Federal Reserve's stance has sparked a tug-of-war between those arguing rate hikes are too far off in the future to worry of a slowdown and those believing the Fed's timeline is still too optimistic. The knee-jerk reaction to its announcement was to buy speculative stocks, including technology, and sell mid-cycle stocks, such as energy. Further confusing the matter, late-cycle baskets, including healthcare and utilities, made the biggest move up in our large-cap sector ranking this week (see below), suggesting we may be closer to an economic reckoning than originally thought.</p>\n<p><b>The best sectors today</b></p>\n<p>Weekly, we rank 1,600 institutional-quality stocks across seven factors. In short, our scoring system incorporates earnings growth, earnings beats, insider buying, short- and long-term money flows, days to cover held short, trends in valuation, and seasonality.</p>\n<p>Once stocks run our gauntlet, we aggregate individual scores by sector to gain insight into the best baskets to over- or under-weight.</p>\n<p>Previously, I've written abouttechnology's relative weaknessin our ranking. The sector still scores below our average universe score, despite catching bids earlier this week. It will be interesting to see if this week's buying spree continues, helping technology climb our ranking, especially since technology doesn't normally score below average for long. For now, staying industry and stock specific in technology still appears to be the best bet.</p>\n<p><img src=\"https://static.tigerbbs.com/5d6585be1d6bfa0b5a61dc98f0ca8c85\" tg-width=\"623\" tg-height=\"421\" referrerpolicy=\"no-referrer\"><i>Source: Top Stocks for Tomorrow.</i></p>\n<p>We also break out our sector scores by market cap every week.</p>\n<p>Often, sectors move up or down in our large-cap ranking sooner than they do in mid cap or small cap; giving investors an early signal of shifting tides. For this reason, paying close attention to the large cap ranking can pay off even if you invest in smaller companies.</p>\n<p>This week, both healthcare and utilities moved up in our large-cap ranking. The improvement could reflect growing clarity into the groups because of the Supreme Court's decision to keep the Affordable Care Act in place and energy strains in Texas, California, and elsewhere, respectively. Perhaps, the move up in these baskets, which are relatively inelastic to economic activity, signals the first Fed Funds rate hike will happen in 2022, not 2023, though.</p>\n<p>Overall, REITs, healthcare, energy, utilities, and financials are top rated in large cap, while technology, consumer goods, and basics score below average. In mid cap, energy, REITs, utilities, and consumer goods are best, while technology, industrials, basics, and healthcare are low scoring. The top small cap sectors are REITs, energy, financials, and services and the lowest-scoring baskets are healthcare, technology, and basics. Focusing on stocks in top-scoring sectors and staying selective in low-scoring sectors could be the best way to find alpha from here.</p>\n<p><img src=\"https://static.tigerbbs.com/440717f3f07f728c62361601e338f285\" tg-width=\"640\" tg-height=\"209\" referrerpolicy=\"no-referrer\"><i>Source: Top Stocks for Tomorrow.</i></p>\n<p><b>The strongest scoring stocks to buy</b></p>\n<p>As I mentioned, we score stocks in our universe weekly, allowing us to rank them from best to worst by screening criteria, such as market cap and sector. For example, the following stock ideas come from our weekly report highlighting the highest-scoring stocks in our universe by sector, regardless of market cap.</p>\n<p>Over 200 stocks made the cut for this report, including the following nine stocks.</p>\n<p>First up, investors ought to think about pharmaceutical stocks given large-cap healthcare is improving in our sector work. Over 20 healthcare stocks made our best stocks list this week, including AbbVie(NYSE:ABBV)and Bristol-Myers Squibb (BMY).</p>\n<p>In the U.S., AbbVie faces-off against generic versions of its mega-blockbuster immunology drug, Humira, in 2023, but up-and-coming top sellers, including Rinvoq and Skyrizi, should helpinsulate it against a drop-off in sales. Botox also provides a nice revenue tailwind because aesthetics demand isalready above pre-COVID levelsthanks to post-vaccination doctor visits. Moonshot-style data is coming soon, too, with trial results in Alzheimer's anticipated this summer and pivotal results from Vraylar's major depressive disorder trials later this year. Finally, since it's paying down debt and still guiding for high single-digit sales growth from 2025 to 2029, despite Humira's loss of exclusivity, its 4.5% dividend appears to be on solid ground.</p>\n<p>Improving post-vaccination trends may make it time to watch Bristol-Myers, too. It's heavily exposed to cancer indications through it's top-selling Opdivo and Yervoy, and earlier this month, managementsaidCOVID-era, double-digit declines in new patient starts for oncology drugs improved to a 5% to 10% decline. If trends continue improving, then oncology drug demand could be back to a pre-COVID levels soon. Similarly, rebounding doctor visits also support sales of Bristol-Myers' Eliquis, a blockbuster oral anticoagulant used in cardiovascular disease.</p>\n<p>Outside of healthcare, energy stocks could make sense given increasing global GDP and inflation forecasts. Oil stocks sold off following the Fed's update last week, however, measured production growth should help keep per barrel prices high at E&amp;P companies, including Hess Corp (HES), while also providing demand tailwinds for services providers, including Oceaneering International (OII).</p>\n<p>Hess Corp'scollaborationoffshore Guyana with Exxon Mobil (XOM) gives it 30% exposure to over 9 billion barrels of oil equivalent in the Stabroek Block, and reserves are climbing thanks to new discoveries. Its breakeven cost in the play ranges from $25 to $35 per barrel of Brent Crude, so with current prices above $70, new production coming online could help boost earnings nicely over the next few years.</p>\n<p>Anoffshore energy projectsplayer, Oceaneering Int'l could see demand for its remotely-operated vehicles (ROVs), subsea project management, and manufactured products, such as umbilicals, increase nicely if offshore activity picks up because of higher per barrel prices. In Q1, ROV fleet utilization was just 53%, yet day rates improved 7% quarter over quarter, and for the full year, management expects fleet utilization to be in thehigh 50%range. With a project in Angola supported project management revenue this year, a potential uptick in book-to-bill for manufactured products, and increasing ROV utilization, it could still be early innings for the company's turnaround.</p>\n<p>There are plenty of ideas outside healthcare and energy, too. For example, nearly 50 technology stocks made our best list, despite the sector scoring below average in our sector ranking, including Microsoft (MSFT) and Shopify (SHOP), which benefit from increasing data in the cloud and e-commerce tailwinds, respectively. Amazon.com (AMZN) is also top-scoring, benefiting from growing e-commerce share of total retail sales and Prime Day, which could add over $10 billion in revenue this year, based on2020's performance.</p>\n<p>Our best list also includes a slate of services stocks, including Stitch Fix (SFIX) and Revolve Group (RVLV). As younger workers refresh wardrobes because post-vaccination, return to office trends, those companies could see a healthy uptake in sales.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Fed Has Spoken: Stocks To Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Fed Has Spoken: Stocks To Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 16:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435924-the-fed-has-spoken-stocks-to-buy-now><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe Fed could begin raising rates sooner than 2023.\nHealthcare and utilities are climbing our sector ranking.\nThe top stocks in our universe today.\n\nAs I wrote last week,inflation is here. ...</p>\n\n<a href=\"https://seekingalpha.com/article/4435924-the-fed-has-spoken-stocks-to-buy-now\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","SHOP":"Shopify Inc","XOM":"埃克森美孚","BMY":"施贵宝","RVLV":"Revolve Group, LLC","SFIX":"Stitch Fix Inc.","AMZN":"亚马逊","MSFT":"微软","HES":"赫斯","OII":"国际海洋工程"},"source_url":"https://seekingalpha.com/article/4435924-the-fed-has-spoken-stocks-to-buy-now","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1124495234","content_text":"Summary\n\nThe Fed could begin raising rates sooner than 2023.\nHealthcare and utilities are climbing our sector ranking.\nThe top stocks in our universe today.\n\nAs I wrote last week,inflation is here. Earlier this week, the Federal Reserve's Federal Open Market Committee made its most significant hawkish shift yet, accelerating its timeline for hiking the Federal Funds rate to 2023 from 2024 and setting the table to end asset repurchases as soon as this year.\nThe Central Bank left little doubt government's one-two monetary and fiscal punch has reinvigorated economic activity. Exiting the meeting, bankers believe gross domestic product, or GDP, willgrow 7%this year, up from its 6.5% forecast in March, resulting in core inflation of 3%, up from its prior outlook for 2.2%.\nHistorically, the Federal Reserve has a reputation for under estimating inflationary pressure, forcing it to act more quickly and aggressively than it originally signals. Whether this means the Fed is behind the inflationary curve now is anyone's guess, but if it is, then we may see an even more hawkish tone over the coming year.\nFor now, the Federal Reserve's stance has sparked a tug-of-war between those arguing rate hikes are too far off in the future to worry of a slowdown and those believing the Fed's timeline is still too optimistic. The knee-jerk reaction to its announcement was to buy speculative stocks, including technology, and sell mid-cycle stocks, such as energy. Further confusing the matter, late-cycle baskets, including healthcare and utilities, made the biggest move up in our large-cap sector ranking this week (see below), suggesting we may be closer to an economic reckoning than originally thought.\nThe best sectors today\nWeekly, we rank 1,600 institutional-quality stocks across seven factors. In short, our scoring system incorporates earnings growth, earnings beats, insider buying, short- and long-term money flows, days to cover held short, trends in valuation, and seasonality.\nOnce stocks run our gauntlet, we aggregate individual scores by sector to gain insight into the best baskets to over- or under-weight.\nPreviously, I've written abouttechnology's relative weaknessin our ranking. The sector still scores below our average universe score, despite catching bids earlier this week. It will be interesting to see if this week's buying spree continues, helping technology climb our ranking, especially since technology doesn't normally score below average for long. For now, staying industry and stock specific in technology still appears to be the best bet.\nSource: Top Stocks for Tomorrow.\nWe also break out our sector scores by market cap every week.\nOften, sectors move up or down in our large-cap ranking sooner than they do in mid cap or small cap; giving investors an early signal of shifting tides. For this reason, paying close attention to the large cap ranking can pay off even if you invest in smaller companies.\nThis week, both healthcare and utilities moved up in our large-cap ranking. The improvement could reflect growing clarity into the groups because of the Supreme Court's decision to keep the Affordable Care Act in place and energy strains in Texas, California, and elsewhere, respectively. Perhaps, the move up in these baskets, which are relatively inelastic to economic activity, signals the first Fed Funds rate hike will happen in 2022, not 2023, though.\nOverall, REITs, healthcare, energy, utilities, and financials are top rated in large cap, while technology, consumer goods, and basics score below average. In mid cap, energy, REITs, utilities, and consumer goods are best, while technology, industrials, basics, and healthcare are low scoring. The top small cap sectors are REITs, energy, financials, and services and the lowest-scoring baskets are healthcare, technology, and basics. Focusing on stocks in top-scoring sectors and staying selective in low-scoring sectors could be the best way to find alpha from here.\nSource: Top Stocks for Tomorrow.\nThe strongest scoring stocks to buy\nAs I mentioned, we score stocks in our universe weekly, allowing us to rank them from best to worst by screening criteria, such as market cap and sector. For example, the following stock ideas come from our weekly report highlighting the highest-scoring stocks in our universe by sector, regardless of market cap.\nOver 200 stocks made the cut for this report, including the following nine stocks.\nFirst up, investors ought to think about pharmaceutical stocks given large-cap healthcare is improving in our sector work. Over 20 healthcare stocks made our best stocks list this week, including AbbVie(NYSE:ABBV)and Bristol-Myers Squibb (BMY).\nIn the U.S., AbbVie faces-off against generic versions of its mega-blockbuster immunology drug, Humira, in 2023, but up-and-coming top sellers, including Rinvoq and Skyrizi, should helpinsulate it against a drop-off in sales. Botox also provides a nice revenue tailwind because aesthetics demand isalready above pre-COVID levelsthanks to post-vaccination doctor visits. Moonshot-style data is coming soon, too, with trial results in Alzheimer's anticipated this summer and pivotal results from Vraylar's major depressive disorder trials later this year. Finally, since it's paying down debt and still guiding for high single-digit sales growth from 2025 to 2029, despite Humira's loss of exclusivity, its 4.5% dividend appears to be on solid ground.\nImproving post-vaccination trends may make it time to watch Bristol-Myers, too. It's heavily exposed to cancer indications through it's top-selling Opdivo and Yervoy, and earlier this month, managementsaidCOVID-era, double-digit declines in new patient starts for oncology drugs improved to a 5% to 10% decline. If trends continue improving, then oncology drug demand could be back to a pre-COVID levels soon. Similarly, rebounding doctor visits also support sales of Bristol-Myers' Eliquis, a blockbuster oral anticoagulant used in cardiovascular disease.\nOutside of healthcare, energy stocks could make sense given increasing global GDP and inflation forecasts. Oil stocks sold off following the Fed's update last week, however, measured production growth should help keep per barrel prices high at E&P companies, including Hess Corp (HES), while also providing demand tailwinds for services providers, including Oceaneering International (OII).\nHess Corp'scollaborationoffshore Guyana with Exxon Mobil (XOM) gives it 30% exposure to over 9 billion barrels of oil equivalent in the Stabroek Block, and reserves are climbing thanks to new discoveries. Its breakeven cost in the play ranges from $25 to $35 per barrel of Brent Crude, so with current prices above $70, new production coming online could help boost earnings nicely over the next few years.\nAnoffshore energy projectsplayer, Oceaneering Int'l could see demand for its remotely-operated vehicles (ROVs), subsea project management, and manufactured products, such as umbilicals, increase nicely if offshore activity picks up because of higher per barrel prices. In Q1, ROV fleet utilization was just 53%, yet day rates improved 7% quarter over quarter, and for the full year, management expects fleet utilization to be in thehigh 50%range. With a project in Angola supported project management revenue this year, a potential uptick in book-to-bill for manufactured products, and increasing ROV utilization, it could still be early innings for the company's turnaround.\nThere are plenty of ideas outside healthcare and energy, too. For example, nearly 50 technology stocks made our best list, despite the sector scoring below average in our sector ranking, including Microsoft (MSFT) and Shopify (SHOP), which benefit from increasing data in the cloud and e-commerce tailwinds, respectively. Amazon.com (AMZN) is also top-scoring, benefiting from growing e-commerce share of total retail sales and Prime Day, which could add over $10 billion in revenue this year, based on2020's performance.\nOur best list also includes a slate of services stocks, including Stitch Fix (SFIX) and Revolve Group (RVLV). As younger workers refresh wardrobes because post-vaccination, return to office trends, those companies could see a healthy uptake in sales.","news_type":1},"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129318394,"gmtCreate":1624358784918,"gmtModify":1703834292604,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Xrp to the moon","listText":"Xrp to the moon","text":"Xrp to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129318394","repostId":"1186919064","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129313243,"gmtCreate":1624358668682,"gmtModify":1703834291955,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Lklpx","listText":"Lklpx","text":"Lklpx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129313243","repostId":"2145056554","repostType":4,"repost":{"id":"2145056554","pubTimestamp":1624356900,"share":"https://www.laohu8.com/m/news/2145056554?lang=&edition=full","pubTime":"2021-06-22 18:15","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half","url":"https://stock-news.laohu8.com/highlight/detail?id=2145056554","media":"Motley Fool","summary":"Here are the companies investors are most excited about -- and why.","content":"<p>The <b>Dow Jones Industrial Average </b>(DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past years. But given everything that's happening in the economy, it's not surprising to see investors rein in their expectations somewhat on some of the top-performing stocks in the market.</p>\n<p>Yet even with the gains the overall market has seen, there are still some Dow stocks that haven't climbed as far as they might. In particular, analysts looking at three stocks among the Dow Jones Industrials see the potential for substantial gains in the second half of 2021 and beyond. Below, we'll look at these three companies to see what it'll take for them to produce the big returns that investors want right now.</p>\n<h3>UnitedHealth: 34% upside</h3>\n<p><b>UnitedHealth Group </b>(NYSE:UNH) has already put in a reasonable performance in the Dow so far this year. The health insurance giant's stock is up about 11% year to date, outpacing the broader average very slightly.</p>\n<p>Yet investors see a lot more upside for the healthcare giant. The top price target among Wall Street analysts for UnitedHealth is $522 per share, which implies roughly a 34% gain from current levels.</p>\n<p>UnitedHealth has done an excellent job of navigating the ever-changing landscape of the healthcare and health insurance industries. As the largest health insurance company in the world, UnitedHealth offers coverage not just for private businesses but also for those eligible for government programs like Medicare and Medicaid.</p>\n<p>Indeed, UnitedHealth's handling of plans under the Affordable Care Act has been masterful, with the company having participated in the program better known as Obamacare while not overcommitting to it. With the Supreme Court having recently upheld the validity of the Affordable Care Act, UnitedHealth finds itself in a strong position to keep benefiting from its mix of business.</p>\n<p><img src=\"https://static.tigerbbs.com/ffe66b7aafd67e07dd42007f2b60d638\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p>Yet many overlook the value of UnitedHealth's Optum health services unit. By aiming to help providers encourage health and wellness, Optum generates higher-margin revenue while often producing better outcomes for patients and members. With both growth drivers pushing the company forward, UnitedHealth looks well poised to keep climbing.</p>\n<h3>Goldman Sachs: 36% upside</h3>\n<p>Wall Street has enjoyed the bull market in stocks, and that's been a blessing for investment bank <b>Goldman Sachs </b>(NYSE:GS). The perennial financial giant has seen its stock rise 34% so far in 2021 after less impressive performance during 2020.</p>\n<p>On <a href=\"https://laohu8.com/S/AONE\">one</a> hand, Goldman has reflected the broader performance of financial stocks across the market. Interest rates have generally been on the rise, and that's bolstered the prospects for more net-interest income from retail banking operations. Goldman lags behind its big-bank peers on the consumer banking front, but its relatively new Marcus unit has done a good job of attracting capital thus far.</p>\n<p>On the other hand, Goldman continues to rely on its investment banking operations, and strong activity levels among initial public offerings and mergers and acquisitions (M&amp;A) have fed the company's coffers nicely. Financing remains relatively easy to get, and that could spur more M&amp;A activity that in turn could keep growing revenue for Goldman's investment banking division. Add to that possible tailwinds from macroeconomic factors, and it is in a solid position to climb as high as the $484 per share that represents the top price target among those following the financial stock.</p>\n<h3>Apple: 42% upside</h3>\n<p>Lastly, <b>Apple </b>(NASDAQ:AAPL) rounds out this list. Recently fetching $130 per share, some see the iPhone maker's stock climbing to $185. That'd be a 42% jump to help Apple recover from its 2% loss so far in 2021.</p>\n<p>Apple's gains have continued to impress. Revenue jumped 54% in its most recent quarter, with sales of the iPhone 12 and various other products and accessories continuing to drive sales for the company. Returning capital to shareholders via dividends and stock buybacks has had a substantial impact on financial performance, especially with the number of outstanding shares having plunged by roughly 35% in just the past decade.</p>\n<p>Many fear that Apple hasn't generated the innovative product lines that drove its success in the mid-2000s. However, at least for now, consumers seem content with iterations on existing product lines, and as long as that remains a successful strategy, further gains for the stock seem realistic.</p>\n<h3>Further to run?</h3>\n<p>Even with solid gains for the Dow in 2021, the long-term trajectory for stocks remains upward. That's a big part of why Apple, Goldman Sachs, and UnitedHealth Group look as promising as they do. Smart investors should at least keep an eye on these three stocks to see if they can live up to their full potential.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 18:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average (DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","09086":"华夏纳指-U","03086":"华夏纳指","UNH":"联合健康","GS":"高盛"},"source_url":"https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145056554","content_text":"The Dow Jones Industrial Average (DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past years. But given everything that's happening in the economy, it's not surprising to see investors rein in their expectations somewhat on some of the top-performing stocks in the market.\nYet even with the gains the overall market has seen, there are still some Dow stocks that haven't climbed as far as they might. In particular, analysts looking at three stocks among the Dow Jones Industrials see the potential for substantial gains in the second half of 2021 and beyond. Below, we'll look at these three companies to see what it'll take for them to produce the big returns that investors want right now.\nUnitedHealth: 34% upside\nUnitedHealth Group (NYSE:UNH) has already put in a reasonable performance in the Dow so far this year. The health insurance giant's stock is up about 11% year to date, outpacing the broader average very slightly.\nYet investors see a lot more upside for the healthcare giant. The top price target among Wall Street analysts for UnitedHealth is $522 per share, which implies roughly a 34% gain from current levels.\nUnitedHealth has done an excellent job of navigating the ever-changing landscape of the healthcare and health insurance industries. As the largest health insurance company in the world, UnitedHealth offers coverage not just for private businesses but also for those eligible for government programs like Medicare and Medicaid.\nIndeed, UnitedHealth's handling of plans under the Affordable Care Act has been masterful, with the company having participated in the program better known as Obamacare while not overcommitting to it. With the Supreme Court having recently upheld the validity of the Affordable Care Act, UnitedHealth finds itself in a strong position to keep benefiting from its mix of business.\n\nImage source: Getty Images.\nYet many overlook the value of UnitedHealth's Optum health services unit. By aiming to help providers encourage health and wellness, Optum generates higher-margin revenue while often producing better outcomes for patients and members. With both growth drivers pushing the company forward, UnitedHealth looks well poised to keep climbing.\nGoldman Sachs: 36% upside\nWall Street has enjoyed the bull market in stocks, and that's been a blessing for investment bank Goldman Sachs (NYSE:GS). The perennial financial giant has seen its stock rise 34% so far in 2021 after less impressive performance during 2020.\nOn one hand, Goldman has reflected the broader performance of financial stocks across the market. Interest rates have generally been on the rise, and that's bolstered the prospects for more net-interest income from retail banking operations. Goldman lags behind its big-bank peers on the consumer banking front, but its relatively new Marcus unit has done a good job of attracting capital thus far.\nOn the other hand, Goldman continues to rely on its investment banking operations, and strong activity levels among initial public offerings and mergers and acquisitions (M&A) have fed the company's coffers nicely. Financing remains relatively easy to get, and that could spur more M&A activity that in turn could keep growing revenue for Goldman's investment banking division. Add to that possible tailwinds from macroeconomic factors, and it is in a solid position to climb as high as the $484 per share that represents the top price target among those following the financial stock.\nApple: 42% upside\nLastly, Apple (NASDAQ:AAPL) rounds out this list. Recently fetching $130 per share, some see the iPhone maker's stock climbing to $185. That'd be a 42% jump to help Apple recover from its 2% loss so far in 2021.\nApple's gains have continued to impress. Revenue jumped 54% in its most recent quarter, with sales of the iPhone 12 and various other products and accessories continuing to drive sales for the company. Returning capital to shareholders via dividends and stock buybacks has had a substantial impact on financial performance, especially with the number of outstanding shares having plunged by roughly 35% in just the past decade.\nMany fear that Apple hasn't generated the innovative product lines that drove its success in the mid-2000s. However, at least for now, consumers seem content with iterations on existing product lines, and as long as that remains a successful strategy, further gains for the stock seem realistic.\nFurther to run?\nEven with solid gains for the Dow in 2021, the long-term trajectory for stocks remains upward. That's a big part of why Apple, Goldman Sachs, and UnitedHealth Group look as promising as they do. Smart investors should at least keep an eye on these three stocks to see if they can live up to their full potential.","news_type":1},"isVote":1,"tweetType":1,"viewCount":87,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129319496,"gmtCreate":1624358602515,"gmtModify":1703834288558,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi! I truly xrp to the moon and i am allIn what about you?","listText":"Hi! I truly xrp to the moon and i am allIn what about you?","text":"Hi! I truly xrp to the moon and i am allIn what about you?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129319496","isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":129380233,"gmtCreate":1624359259622,"gmtModify":1703834301199,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Fake","listText":"Fake","text":"Fake","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129380233","repostId":"1177499959","repostType":4,"isVote":1,"tweetType":1,"viewCount":139,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129313243,"gmtCreate":1624358668682,"gmtModify":1703834291955,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Lklpx","listText":"Lklpx","text":"Lklpx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129313243","repostId":"2145056554","repostType":4,"repost":{"id":"2145056554","pubTimestamp":1624356900,"share":"https://www.laohu8.com/m/news/2145056554?lang=&edition=full","pubTime":"2021-06-22 18:15","market":"us","language":"en","title":"These 3 Dow Stocks Are Set to Soar in 2021's Second Half","url":"https://stock-news.laohu8.com/highlight/detail?id=2145056554","media":"Motley Fool","summary":"Here are the companies investors are most excited about -- and why.","content":"<p>The <b>Dow Jones Industrial Average </b>(DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past years. But given everything that's happening in the economy, it's not surprising to see investors rein in their expectations somewhat on some of the top-performing stocks in the market.</p>\n<p>Yet even with the gains the overall market has seen, there are still some Dow stocks that haven't climbed as far as they might. In particular, analysts looking at three stocks among the Dow Jones Industrials see the potential for substantial gains in the second half of 2021 and beyond. Below, we'll look at these three companies to see what it'll take for them to produce the big returns that investors want right now.</p>\n<h3>UnitedHealth: 34% upside</h3>\n<p><b>UnitedHealth Group </b>(NYSE:UNH) has already put in a reasonable performance in the Dow so far this year. The health insurance giant's stock is up about 11% year to date, outpacing the broader average very slightly.</p>\n<p>Yet investors see a lot more upside for the healthcare giant. The top price target among Wall Street analysts for UnitedHealth is $522 per share, which implies roughly a 34% gain from current levels.</p>\n<p>UnitedHealth has done an excellent job of navigating the ever-changing landscape of the healthcare and health insurance industries. As the largest health insurance company in the world, UnitedHealth offers coverage not just for private businesses but also for those eligible for government programs like Medicare and Medicaid.</p>\n<p>Indeed, UnitedHealth's handling of plans under the Affordable Care Act has been masterful, with the company having participated in the program better known as Obamacare while not overcommitting to it. With the Supreme Court having recently upheld the validity of the Affordable Care Act, UnitedHealth finds itself in a strong position to keep benefiting from its mix of business.</p>\n<p><img src=\"https://static.tigerbbs.com/ffe66b7aafd67e07dd42007f2b60d638\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p>Yet many overlook the value of UnitedHealth's Optum health services unit. By aiming to help providers encourage health and wellness, Optum generates higher-margin revenue while often producing better outcomes for patients and members. With both growth drivers pushing the company forward, UnitedHealth looks well poised to keep climbing.</p>\n<h3>Goldman Sachs: 36% upside</h3>\n<p>Wall Street has enjoyed the bull market in stocks, and that's been a blessing for investment bank <b>Goldman Sachs </b>(NYSE:GS). The perennial financial giant has seen its stock rise 34% so far in 2021 after less impressive performance during 2020.</p>\n<p>On <a href=\"https://laohu8.com/S/AONE\">one</a> hand, Goldman has reflected the broader performance of financial stocks across the market. Interest rates have generally been on the rise, and that's bolstered the prospects for more net-interest income from retail banking operations. Goldman lags behind its big-bank peers on the consumer banking front, but its relatively new Marcus unit has done a good job of attracting capital thus far.</p>\n<p>On the other hand, Goldman continues to rely on its investment banking operations, and strong activity levels among initial public offerings and mergers and acquisitions (M&amp;A) have fed the company's coffers nicely. Financing remains relatively easy to get, and that could spur more M&amp;A activity that in turn could keep growing revenue for Goldman's investment banking division. Add to that possible tailwinds from macroeconomic factors, and it is in a solid position to climb as high as the $484 per share that represents the top price target among those following the financial stock.</p>\n<h3>Apple: 42% upside</h3>\n<p>Lastly, <b>Apple </b>(NASDAQ:AAPL) rounds out this list. Recently fetching $130 per share, some see the iPhone maker's stock climbing to $185. That'd be a 42% jump to help Apple recover from its 2% loss so far in 2021.</p>\n<p>Apple's gains have continued to impress. Revenue jumped 54% in its most recent quarter, with sales of the iPhone 12 and various other products and accessories continuing to drive sales for the company. Returning capital to shareholders via dividends and stock buybacks has had a substantial impact on financial performance, especially with the number of outstanding shares having plunged by roughly 35% in just the past decade.</p>\n<p>Many fear that Apple hasn't generated the innovative product lines that drove its success in the mid-2000s. However, at least for now, consumers seem content with iterations on existing product lines, and as long as that remains a successful strategy, further gains for the stock seem realistic.</p>\n<h3>Further to run?</h3>\n<p>Even with solid gains for the Dow in 2021, the long-term trajectory for stocks remains upward. That's a big part of why Apple, Goldman Sachs, and UnitedHealth Group look as promising as they do. Smart investors should at least keep an eye on these three stocks to see if they can live up to their full potential.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Dow Stocks Are Set to Soar in 2021's Second Half</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Dow Stocks Are Set to Soar in 2021's Second Half\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 18:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average (DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","09086":"华夏纳指-U","03086":"华夏纳指","UNH":"联合健康","GS":"高盛"},"source_url":"https://www.fool.com/investing/2021/06/22/these-3-dow-stocks-set-to-soar-2021s-second-half/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145056554","content_text":"The Dow Jones Industrial Average (DJINDICES:^DJI) has had a solid year so far in 2021. Gains of 9% might not seem like all that much compared to the double-digit percentage gains we've seen in past years. But given everything that's happening in the economy, it's not surprising to see investors rein in their expectations somewhat on some of the top-performing stocks in the market.\nYet even with the gains the overall market has seen, there are still some Dow stocks that haven't climbed as far as they might. In particular, analysts looking at three stocks among the Dow Jones Industrials see the potential for substantial gains in the second half of 2021 and beyond. Below, we'll look at these three companies to see what it'll take for them to produce the big returns that investors want right now.\nUnitedHealth: 34% upside\nUnitedHealth Group (NYSE:UNH) has already put in a reasonable performance in the Dow so far this year. The health insurance giant's stock is up about 11% year to date, outpacing the broader average very slightly.\nYet investors see a lot more upside for the healthcare giant. The top price target among Wall Street analysts for UnitedHealth is $522 per share, which implies roughly a 34% gain from current levels.\nUnitedHealth has done an excellent job of navigating the ever-changing landscape of the healthcare and health insurance industries. As the largest health insurance company in the world, UnitedHealth offers coverage not just for private businesses but also for those eligible for government programs like Medicare and Medicaid.\nIndeed, UnitedHealth's handling of plans under the Affordable Care Act has been masterful, with the company having participated in the program better known as Obamacare while not overcommitting to it. With the Supreme Court having recently upheld the validity of the Affordable Care Act, UnitedHealth finds itself in a strong position to keep benefiting from its mix of business.\n\nImage source: Getty Images.\nYet many overlook the value of UnitedHealth's Optum health services unit. By aiming to help providers encourage health and wellness, Optum generates higher-margin revenue while often producing better outcomes for patients and members. With both growth drivers pushing the company forward, UnitedHealth looks well poised to keep climbing.\nGoldman Sachs: 36% upside\nWall Street has enjoyed the bull market in stocks, and that's been a blessing for investment bank Goldman Sachs (NYSE:GS). The perennial financial giant has seen its stock rise 34% so far in 2021 after less impressive performance during 2020.\nOn one hand, Goldman has reflected the broader performance of financial stocks across the market. Interest rates have generally been on the rise, and that's bolstered the prospects for more net-interest income from retail banking operations. Goldman lags behind its big-bank peers on the consumer banking front, but its relatively new Marcus unit has done a good job of attracting capital thus far.\nOn the other hand, Goldman continues to rely on its investment banking operations, and strong activity levels among initial public offerings and mergers and acquisitions (M&A) have fed the company's coffers nicely. Financing remains relatively easy to get, and that could spur more M&A activity that in turn could keep growing revenue for Goldman's investment banking division. Add to that possible tailwinds from macroeconomic factors, and it is in a solid position to climb as high as the $484 per share that represents the top price target among those following the financial stock.\nApple: 42% upside\nLastly, Apple (NASDAQ:AAPL) rounds out this list. Recently fetching $130 per share, some see the iPhone maker's stock climbing to $185. That'd be a 42% jump to help Apple recover from its 2% loss so far in 2021.\nApple's gains have continued to impress. Revenue jumped 54% in its most recent quarter, with sales of the iPhone 12 and various other products and accessories continuing to drive sales for the company. Returning capital to shareholders via dividends and stock buybacks has had a substantial impact on financial performance, especially with the number of outstanding shares having plunged by roughly 35% in just the past decade.\nMany fear that Apple hasn't generated the innovative product lines that drove its success in the mid-2000s. However, at least for now, consumers seem content with iterations on existing product lines, and as long as that remains a successful strategy, further gains for the stock seem realistic.\nFurther to run?\nEven with solid gains for the Dow in 2021, the long-term trajectory for stocks remains upward. That's a big part of why Apple, Goldman Sachs, and UnitedHealth Group look as promising as they do. Smart investors should at least keep an eye on these three stocks to see if they can live up to their full potential.","news_type":1},"isVote":1,"tweetType":1,"viewCount":87,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9099041601,"gmtCreate":1643283522511,"gmtModify":1676533795948,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I love this game","listText":"I love this game","text":"I love this game","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099041601","repostId":"9004448317","repostType":1,"repost":{"id":9004448317,"gmtCreate":1642676525258,"gmtModify":1676533734534,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"Join Tiger Ski Championship, Win a Bonus of Up to USD 2022","htmlText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","listText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","text":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: Click to Join the Game","images":[{"img":"https://static.tigerbbs.com/a7b44fa056439fb4010fa55e163d27c3","width":"750","height":"1726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004448317","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129389626,"gmtCreate":1624359293065,"gmtModify":1703834302168,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Xrp i think will moon","listText":"Xrp i think will moon","text":"Xrp i think will moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129389626","repostId":"2145803031","repostType":4,"isVote":1,"tweetType":1,"viewCount":122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129316188,"gmtCreate":1624358845344,"gmtModify":1703834293573,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I thikk no leh","listText":"I thikk no leh","text":"I thikk no leh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129316188","repostId":"1124495234","repostType":4,"isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9099043316,"gmtCreate":1643283386202,"gmtModify":1676533795923,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Pltr will moon soon ipo price rn","listText":"Pltr will moon soon ipo price rn","text":"Pltr will moon soon ipo price rn","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9099043316","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009883991,"gmtCreate":1640610145877,"gmtModify":1676533528807,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I think xrp will moon","listText":"I think xrp will moon","text":"I think xrp will moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009883991","isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129389358,"gmtCreate":1624359277674,"gmtModify":1703834301683,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Daftpunk better","listText":"Daftpunk better","text":"Daftpunk better","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129389358","repostId":"1139414035","repostType":4,"isVote":1,"tweetType":1,"viewCount":123,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129380832,"gmtCreate":1624359246026,"gmtModify":1703834301037,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129380832","repostId":"1186855284","repostType":4,"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129318394,"gmtCreate":1624358784918,"gmtModify":1703834292604,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Xrp to the moon","listText":"Xrp to the moon","text":"Xrp to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129318394","repostId":"1186919064","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129319496,"gmtCreate":1624358602515,"gmtModify":1703834288558,"author":{"id":"3586344416928957","authorId":"3586344416928957","name":"Kahsiang","avatar":"https://static.tigerbbs.com/a49ffe0a98a80e92eabdcd3135e0ac1b","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi! I truly xrp to the moon and i am allIn what about you?","listText":"Hi! I truly xrp to the moon and i am allIn what about you?","text":"Hi! I truly xrp to the moon and i am allIn what about you?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/129319496","isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}